Debt to Equity Ratio Chart

View Debt to Equity Ratio for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2013. Start Trial.
Date Value
March 31, 2026 2.176
December 31, 2025 2.326
September 30, 2025 2.519
June 30, 2025 2.666
March 31, 2025 2.895
December 31, 2024 3.199
September 30, 2024 1.98
June 30, 2024 2.047
March 31, 2024 1.936
December 31, 2023 1.895
September 30, 2023 1.898
June 30, 2023 1.805
March 31, 2023 1.901
December 31, 2022 1.907
September 30, 2022 1.915
June 30, 2022 1.793
March 31, 2022 1.707
December 31, 2021 1.817
September 30, 2021 1.881
June 30, 2021 1.789
March 31, 2021 1.915
December 31, 2020 1.926
September 30, 2020 2.189
June 30, 2020 2.182
March 31, 2020 1.996
Date Value
December 31, 2019 1.827
September 30, 2019 2.017
June 30, 2019 1.51
March 31, 2019 1.540
December 31, 2018 1.580
September 30, 2018 1.689
June 30, 2018 1.689
March 31, 2018 1.667
December 31, 2017 1.880
September 30, 2017 1.958
June 30, 2017 2.072
March 31, 2017 2.220
December 31, 2016 2.917
September 30, 2016 3.350
June 30, 2016 3.898
March 31, 2016 4.716
December 31, 2015 5.724
September 30, 2015 13.55
June 30, 2015 9.772
March 31, 2015 12.45
December 31, 2014 11.06
September 30, 2014 13.36
June 30, 2014 19.10
March 31, 2014 -4.757
December 31, 2013 -5.727

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Zoetis, Inc. 2.935
Merck & Co., Inc. 1.286
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945